MedPath

Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma

Conditions
Oropharyngeal Squamous Cell Carcinoma
Oral Cavity Squamous Cell Carcinoma
Registration Number
NCT03727594
Lead Sponsor
University Hospital of Ferrara
Brief Summary

The purpose of the study is to assess the role of lymphoscintigraphy as a simple and widely accessible method with a favorable cost/benefit ratio in improving oral cavity and oropharyngeal squamous cell carcinoma staging and surgical appropriateness and implementing a tailored surgical approach to cervical lymph node dissection.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • accepted informed consent
  • preoperative histological diagnosis of oral cavity or oropharyngeal squamous cell carcinoma
  • patients fit to surgery of the primitive tumor and neck dissection (according to the general health condition and the clinical tumor stage)
Exclusion Criteria
  • rejected informed consent
  • patients not fit to surgery (according to the general health condition and the clinical tumor stage)
  • pregnant women

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival5 years

Prognosis of radioguided neck dissection surgery compared to the standardized neck dissection traditionally performed in consideration of the site and the characteristics of the tumor and the clinical status of lymphnodes.

Number of patients with atypical lymphatic drainage of oral cavity and oropharyngeal squamous cell carcinoma identified through lymphoscintigraphy5 years
Number of metastasis or micrometastasis in the "sentinel" lymphnodes identified through immunofluorescence analysis of pancytokeratins5 years
Disease-free survival5 years

Prognosis of radioguided neck dissection surgery compared to the standardized neck dissection traditionally performed in consideration of the site and the characteristics of the tumor and the clinical status of lymphnodes.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital of Ferrara

🇮🇹

Ferrara, Italy

© Copyright 2025. All Rights Reserved by MedPath